Found 14 resultsAuthor [ Title] Type Year
Filters: Author is Wu, J [Clear All Filters]
Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study. Blood, 119, 3854-3860. presented at the 04/2012.. (2012).
Alternative Donor Transplantation: Results of Parallel Phase II Trials Using HLA-Mismatched Related Bone Marrow or Unrelated Umbilical Cord Blood Grafts. Blood, 118, 282-288. presented at the 07/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21527516. (2011).
Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402. Bone Marrow Transplant, 53(1), 64-68. presented at the 2018 01. doi:10.1038/bmt.2017.236. (2018).
Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Biol Blood Marrow Transplant, 20, 1530-1536. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24910380. (2014).
Graft-versus-Host Disease Treatment: Predictors of Survival. Biol Blood Marrow Transplant, 16, 1693-1699. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20541024. (2010).
GVHD Biomarkers Measured During Treatment Independently Predict Response to Therapy and Survival: A Blood and Marrow Transplant Clinical Trials Network Study (Abstract). In . presented at the 2011, Paris, France. Retrieved from http://www.congrex.ch/ebmt2011/. (2011).
Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naive T Cells from Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201. J Clin Oncol, 32, 2365-2372. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982459. (2014).
Information-Seeking Behaviors of Dental Practitioners in Three Practice-Based Research Networks. J Dent Educ, 77, 152-160. presented at the 02/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23382524. (2013).
Lymphocyte Phenotype During Therapy for Acute Graft Versus Host Disease: A Brief Report from BMT CTN 0302. Biol Blood Marrow Transplant, 19, 481-485. presented at the 03/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23247045. (2013).
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies. Biol Blood Marrow Transplant, 20, 1485-1492. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24862638. (2014).
Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-Versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant, 16, 421-429. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19925875. (2010).
Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol. Biol Blood Marrow Transplant, 20, 858-864. presented at the 06/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24607553. (2014).
Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT. Blood, 124, 1372-1377. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982504. (2014).
Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).